Related Experiment Video
Updated: Jan 25, 2026

Single-cell Transcriptomic Analyses of Mouse Pancreatic Endocrine Cells
Published on: September 30, 2018
Infantile-Onset Multisystem Neurologic, Endocrine, and Pancreatic Disease: Case and Review
Christine Le1,2, Asuri N Prasad1,3,4,2, C Anthony Rupar3,4,2
1Department of Clinical Neurological Sciences, London, Ontario, Canada.
Insights
A novel PTRH2 gene mutation causes infantile-onset multisystem disease affecting neurologic, endocrine, and pancreatic functions. This genetic discovery offers insights into rare pediatric disorders.
Area of Science:
- Genetics
- Neurology
- Endocrinology
Background:
- Infantile-onset multisystem neurologic, endocrine, and pancreatic disease (IMNEPD) is a rare genetic disorder.
- Understanding the genetic basis of IMNEPD is crucial for diagnosis and potential therapeutic strategies.
Observation:
- Three brothers from a consanguineous Syrian family presented with a novel homozygous nonsense mutation (c.324G>A, p.W108*) in the PTRH2 gene.
- Clinical manifestations included postnatal microcephaly, motor and language delay with regression, ataxia, hearing loss, epileptic seizures, pancreatic insufficiency, and peripheral neuropathy.
Findings:
- The identified homozygous mutation in PTRH2, encoding peptidyl-tRNA hydrolase 2, is directly linked to the observed IMNEPD phenotype.
- Detailed clinical phenotyping facilitated the precise genetic investigation and identification of this novel mutation.
Implications:
- This study expands the known genetic causes of IMNEPD and highlights the role of PTRH2.
- The findings contribute to the understanding of multisystemic genetic disorders and may inform future research on IMNEPD and related conditions.
Abstract:
We report three brothers born to consanguineous parents of Syrian descent, with a homozygous novel c.324G>A (p.W108*) mutation in PTRH2 that encodes peptidyl-tRNA hydrolase 2, causing infantile-onset multisystem neurologic, endocrine, and pancreatic disease (IMNEPD). We describe the core clinical features of postnatal microcephaly, motor and language delay with regression, ataxia, and hearing loss. Additional features include epileptic seizures, pancreatic insufficiency, and peripheral neuropathy. Clinical phenotyping enabled a targeted approach to the investigation and identification of a novel homozygous nonsense mutation in PTRH2, c.324G>A (p.W108*). We compare our patients with those recently described and review the current literature for IMNEPD.
Related Concept Videos
Endocrine Signaling
What is the Endocrine System?
The Endocrine System
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
An Overview of the Endocrine System
The endocrine system collaborates...

